The waveLINE-003 trial demonstrates the efficacy of zilovertamab vedotin combined with standard therapy, with manageable safety profiles in difficult-to-treat DLBCL patients. ADCs provide logistical ...

Law enforcement released photos of a person “in proximity of the person of interest” in the shooting and a map showing where ...

Finding the right vagus nerve stimulation device can be tricky; TPIMS reviewed dozens and found the most effective options ...

NHS 111, more commonly regarded as a service for handling minor physical ailments, is also equipped to provide mental health assistance. Anyone in need of help can press option two to access a range ...

Research labs led by associate professor Christine Chaffer and professor Alexander Swarbrick are now world leaders in ...

Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has signaled smart money ...

Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...

A child who received the world's first personalized CRISPR therapy is now taking his first steps after months in hospital ...

Significant treatment options are changing the management of CLL, according to research presented at the ASH Annual Meeting 2025.

Once limited to nonspecific anti-inflammatory therapies, expanding treatment options for atopic dermatitis are allowing therapy to be individualized.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

President Trump signed an executive order on Thursday to downgrade cannabis from the most restrictive category of drugs like ...